Global Autoinjector Market
www.vynzresearch.com
enquiry@vynzresearch.com
Industry Overview The global autoinjectors market is anticipated to grow at a CAGR of 16.9% during the forecast period with its market size reaching USD 4.5 billion by 2024. The market is growing at a significant rate due to mounting occurrence chronic and lifestyle associated diseases, escalating occurrence of anaphylaxis, and advancement in technology. Autoinjectors is a small device designed to deliver a specific dose of a particular drug. These are usually spring-loaded syringes that are mainly invented for comfortable and safe dispensation of the drugs. Different autoinjector products including prefilled and fillable injectors contributed to the autoinjectors market size. The market has witnessed high demand for disposable autoinjectors in the coming years due to advantages of disposable autoinjectors such as handiness, less probability of infection, and easiness of use. Explore Full Report Description at: https:// www.vynzresearch.com/healthcare/autoinjectors-market
market segmentation  Based on product, the autoinjector market is categorized into prefilled and fillable injectors. Of the two products, prefilled injectors hold the larger share in the market and it is predicted that the product category will also grow at the faster rate during the forecast period.
Geographic Overview  Geographically, North America is the largest autoinjectors market as in the region the occurrence of chronic and autoimmune disease is increasing. For instance, according to Centers for Disease Control and Prevention (CDC), in 2015 approximately 23.1 million people in the U.S. had diabetes.  In addition, mounting occurrence of anaphylaxis, mounting healthcare expenditure and promising reimbursement situation are also up surging growth of the North American autoinjectors market. For instance, according to the National Health Interview Survey (NHIS), in 2014, 5.4 percent US children under age 18 suffered from food allergy. In addition, according to Food Allergy Research & Education, approximately 15 million Americans have food allergies.
Competition among key players  Key players in the autoinjectors market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In December 2016, Mylan N.V. launched the authorized generic for EpiPen, as an autoinjector. Abbvie, Ypsomed, Consort Medical, Johnson & Johnson, Mylan, Becton, Dickinson and Company, Amgen, Haselmeier, ELI Lilly, Owen Mumford, Scandinavian Health Limited and Antares Pharma are the key players offering autoinjectors.
In
THANK YOU!
https:// www.vynzresearch.com/healthcare/autoinjectors-market/request-sample
enquiry@vynzresearch.com US/Canada Toll-Free: 1-888-253-
www.vynzresearch.com